Talphera (TLPH) Revenue (2011 - 2025)

Talphera (TLPH) posted quarterly Revenue of $1000.0 for Q3 2025, down 96.3% quarter-over-quarter from $27000.0 in Q1 2025.

Talphera (TLPH) Revenue (2011 - 2025) Analysis & Trends

Talphera's Revenue history runs 14 years deep, the most recent figure standing at $1000.0 for Q3 2025.

In Q3 2025, Revenue changed N/A year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $1000.0 (down 96.3% YoY), while the FY2025 annual figure was $28000.0, changed N/A from the prior year.
Revenue for Q3 2025 stood at $1000.0, down from $27000.0 in the prior quarter.
The five-year high for Revenue was $1.7 million in Q3 2021, with the low at $1000.0 in Q3 2025.
The 4-year median for Revenue is $281000.0 (2023), against an average of $388909.1.
Peak annual rise in Revenue reached 32.38% in 2021, while the deepest fall reached 99.73% in 2021.
Talphera's Revenue stood at $2000.0 in 2021, then surged by 22000.0% to $442000.0 in 2022, then sank by 36.43% to $281000.0 in 2023, then slumped by 99.64% to $1000.0 in 2025.
Business Quant data shows TLPH's Revenue at $1000.0 in Q3 2025, $27000.0 in Q1 2025, and $281000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Haleon	43.71 Bn	42.75 Bn	-	-
2	Teva Pharmaceutical Industries	43.11 Bn	39.45 Bn	2.15 Bn	4.14 Bn
3	Zoetis	31.62 Bn	29.94 Bn	1.05 Bn	2.47 Bn
4	Takeda Pharmaceutical	28.72 Bn	22.92 Bn	5.10 Bn	7.65 Bn
5	United Therapeutics	22.33 Bn	19.67 Bn	683.80 Mn	783.30 Mn
6	Viatris	18.83 Bn	17.95 Bn	1.46 Bn	3.76 Bn
7	Neurocrine Biosciences	15.62 Bn	15.23 Bn	935.80 Mn	959.00 Mn
8	Elanco Animal Health	12.10 Bn	11.57 Bn	798.00 Mn	1.37 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Talphera	89.88 Mn	89.88 Mn	-	-

Download Data